| Date Filed | Type | Description |
| 03/31/2023 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on 9 METERS BIOPHARMA, INC.|
Txns:
| Granted 7,885 shares
@ $0 |
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2020 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Exercised (in-or-at-the-money) 4,262 options to buy
@ $4, valued at
$17k
|
|
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 848 convertible preferred
@ $0
Bought 848 options to buy
@ $0 |
|
| 05/04/2020 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.6, valued at
$15k
|
|
| 02/14/2020 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 11,389 options to buy
@ $3.16, valued at
$36k
|
|
| 01/13/2020 |
4/A
| JOHNSON LORIN K (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 8,524 shares
@ $4.11, valued at
$35k
Granted 6,393 options to buy
@ $4.8, valued at
$30.7k
Granted 4,262 options to buy
@ $4, valued at
$17k
|
|
| 01/10/2020 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 8,524 shares
@ $4.11, valued at
$35k
Bought 6,393 options to buy
@ $4.8, valued at
$30.7k
Bought 4,262 options to buy
@ $4, valued at
$17k
|
|
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2019 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $1.28, valued at
$32k
|
|
| 12/07/2018 |
4
| JOHNSON LORIN K (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.41, valued at
$60.3k
|
|
| 02/08/2018 |
3
| JOHNSON LORIN K (Director) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC. |
| 02/14/2003 |
SC 13G/A
| JOHNSON LORIN K reports a 4.1% stake in Salix Pharmaceuticals, Ltd. |
| 02/14/2002 |
SC 13G/A
| JOHNSON LORIN K reports a 5.3% stake in Salix Pharmaceuticals, Ltd. |
| 02/14/2001 |
SC 13G/A
| JOHNSON LORIN K reports a 6.5% stake in Salix Pharmaceuticals, Ltd. |
| 02/15/2000 |
SC 13G/A
| JOHNSON LORIN K reports a 7.7% stake in Salix Pharmaceuticals, Ltd. |
| 02/08/1999 |
SC 13G/A
| JOHNSON LORIN K reports a 7% stake in SALIX PHARMACEUTICALS, LTD. |
| 02/13/1998 |
SC 13G
| JOHNSON LORIN K reports a 7% stake in SALIX HOLDINGS, LTD. |